The company added that Zoledronic Acid Injectionin the 5 mg/100 mL Single Dose Vial is the generic version of Novartis' Reclast
Boniva also is administered as an intravenous injection, as is another bisphosphonate, zoledronic acid (Reclast
side effects incapacitate patient [Web page].
Trial Long-Term Extension (FLEX)", "the Reclast
Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly--Pivotal Fracture Trial (HORIZONPFT) Extension" ve "the Actonel Vertebral Efficacy with Risedronate Therapy--Multinational Trial (VERT-MN) extension" calismalarina dayanarak, hastalarin 3-5 yildan uzun sureli bifosfonat tedavisinden yarar gormedikleri ve tedavinin kesilmesinden sonra bifosfonatlarin yararli etkilerinin ne kadar sure ile devam ettiginin ongorulmesinin zor oldugu ileri surulmustur (64).
has recently been approved by the FDA to prevent postmenopausal osteoporosis for two years with a single dose.
But bisphosphonates -- such as Merck's Fosamax, Roche's Boniva, Novartis's Reclast
, and Warner Chilcott's Actonel -- remain the most popular option, and can be bought for as little as $10 per month in the US.
review, published in The New England Journal of Medicine online recently, was prompted by a growing debate over how long women should continue using the drugs, known as bisphosphonates, which are sold as generic versions of brands like Fosamax and Boniva, as well as Novartis's Reclast
Similarly, the dosage with which a drug is administrated, can uncover the patient's condition, for example, the drug Reclast
is usually used in lower doses to prevent osteoporosis but is used in higher doses to treat bone cancer.
The NWHN will use all the advocacy tools at its disposal to press the FDA to make changes in how drug companies are allowed to market bisphosphonates like Fosamax, Actonel, Boniva and Reclast
(as well as the many generic bisphosphonates) to healthy women.
The drugs affected are Actonel; Actonel Plus Calcium; Atelvia; Boniva; Fosamax; Fosamax Plus D; and Reclast
, as well as their generic offspring.
Doctors prescribing Zometa to block the return of tumors "should stop or at least question that practice." Zometa, given as an infusion, also is sold at a lower dose under the name Reclast
or Aclasta to treat osteoporosis.